No Detail Found!

Formulation Development and Assessment of Naproxen Sodium Tablet (Anti Rheumatic Agent).

Author(s)
Fatima Qamar Faculty of Pharmacy, Jinnah University for Women, Karachi, Pakistan
Samina Alam Faculty of Pharmacy, Jinnah University for Women, Karachi, Pakistan
Safila Naveed Faculty of Pharmacy, Jinnah University for Women, Karachi, Pakistan
Fouzia Hamid Faculty of Pharmacy, Jinnah University for Women, Karachi, Pakistan
Halima Sadia Faculty of Pharmacy, Jinnah University for Women, Karachi, Pakistan
Sidrah Khan Faculty of Pharmacy, Jinnah University for Women, Karachi, Pakistan
Abstract
Background: Naproxen sodium has been extensively used as an anti-pyretic, anti-inflammatory and analgesic agent. Naproxen sodium tablet contains nonactive ingredients like maize starch, microcrystalline cellulose, cross povidone, cross carmellose, lactose mono hydrate and magnesium stearate. Objective: The objective of the study is to devise a method which caters to diverse aspects such as manufacturing and analysis associated with Naproxen Sodium. Methods: All these non-active ingredients were blend with active using wet granulation technique. Different disintegrating agents were used for the enhancement of dissolution and disintegration property of newly formulated pharmaceutical product. In-process and finished product quality control tests were conduct which include weight variation test, uniformity test, hardness test, disintegration and dissolution test. UV spectrophotometer and HPLC analysis was also performed. Conclusion: The results were found satisfactory plus the new formulation of naproxen sodium tablet passed the all criteria for analysis as specified in the BP/USP. The percent assay of granules was performed by both techniques that are HPLC and UV spectroscopy. The percent pharmaceutical assay, the individual weights, average weights, thickness, disintegration time of core and coated tablets, hardness and friability of core tablets plus dissolution test of coated tablets met the limits specified in the BP and USP.
Publication Details
Page(s) 30-36
DOI DOI not available
Published Journal: RADS Journal of Pharmacy & Pharmaceutical Sciences, Volume: 5, Issue: 3, Year: 2017

Request the full text from PASTIC

Keywords
dissolution test, formulation development, HPLC.UV spectrophotometer
References
RobertsDN,MinerPB, 2011.Safety aspects and rational use of a naproxen+ esomeprazole combination in the treatment of rheumatoid disease,Drug Healthc Patient Saf 3 1 -
DerryC,DerryS,MooreRA,McQuayHJ, 2009.Single dose oral naproxen and naproxen sodium for acute postoperative pain in adults,Cochrane Database Syst Rev -
WheltonA,SchulmanG,WallemarkC,DrowerEJ,IsaksonPC,VerburgKM,GeisGS, 2000.Effects of celecoxib and naproxen on renal function in the elderly,Arch Intern Med 160 1465 -70
BrogdenRN,HeelRC,SpeightTM,AveryGS, 1979.Naproxen up to date: a review of its pharmacological properties and therapeutic efficacy and use in rheumatic diseases and pain states,Drugs 18 241 -77
ZhangWY, 1998.Li Wan Po A. Efficacy of minor analgesics in primary dysmenorrhoea: a systematic review,Int J Gynaecol Obstet 105 780 -9
MattssonS., .Pharmaceutical binders and their function in directly compressed tablets: Mechanistic studies on the effect of dry binders on mechanical strength, pore structure and disintegration of tablets (Doctoral dissertation,Acta Universitatis Upsaliensis). -
SamAP,FokkensJG, 1997.The Drug Delivery System: Adding Therapeutic and Economic Value to Pharmacotherapy, Part II,Pharmaceutical Technology Europe 9 58 -67
YasmeenR,ShoaibMH,KhalidH, 2005.Comparative study of different formulations of atenolol,Biochem Biophys Acta 577 346 -59
ZafarF,ShoaibMH,YusufRI, 2012.Formulation Development of Fexofenadine 120 mg Tablet by Direct Compression Method,Int. J. Adv. Pharm. Res 3 784 -9
AultonME, 2002.Pharmaceutics: The science of dosage form design, -
FaureA,YorkP,RoweRC, 2001.Process control and scale-up of pharmaceutical wet granulation processes: a review,Eur J Pharm Biopharm 52 269 -77
DilshadH,NaveedS,JamilS,NaqviSB, 2014.Formulations of Isosorbidemononitrate (Ismn) tablet and comparative study with available brands,Int Res J Pharm 5 168 -71
Huynh-BaK, 2008.,Handbook of stability testing in pharmaceutical development: regulations, methodologies, and best practices -
Huynh-BaK.,Introduction, 2009.,InHandbook of Stability Testing in Pharmaceutical Development 1 -6
JainSK,SoniV, 2012.Bentley's Textbook of Pharmaceutics, -
RemingtonJP, 2006.Remington: the science and practice of pharmacy,Lippincott Williams & Wilkins; -
TroyDB,HauberM., 21st.Remington: The science and practice of pharmacy, -
BajajS,SinglaD,SakhujaN., .Stability Testing of Pharmaceutical Products, -
QiuY,ChenY,ZhangGG,LiuL,PorterW, 2009.,Developing solid oral dosage forms: pharmaceutical theory & practice -
QiuY,ChenY,ZhangGG,LiuL,PorterW, 2009.,Developing solid oral dosage forms: pharmaceutical theory & practice -
BrownW,MarquesMR, 2013.,. 14 The United States Pharmacopeia/National Formulary. Generic Drug Product Development: Solid Oral Dosage Forms 24 319 -
BakshiM,Singh S, .Development of validated stability-indicating assay methods-critical review,J Pharm Biomed Anal. 2002 Jun 15 1011 -40
0

Citations

0

Downloads

126

Views